Literature DB >> 26170420

Motor vehicle accidents and obstructive sleep apnea syndrome: A methodology to calculate the related burden of injuries.

Sergio Garbarino1, Alessio Pitidis2, Marco Giustini2, Franco Taggi2, Antonio Sanna3.   

Abstract

The association between motor vehicle accidents (MVAs) and obstructive sleep apnea syndrome (OSAS) has always been quantified as risk of MVAs for individual drivers with OSAS. We evaluated the expected injured patients per year attributable to OSAS-dependent MVAs in a general population. By combining OSAS prevalence and OSAS-dependent MVAs odds ratio, we assessed the population attributable fraction (PAF), an epidemiological tool that can be used to quantify the proportion of road traffic injuries (RTIs) attributable to OSAS. For an apnea hypopnea index >5, the weighed median and combined average of OSAS prevalence were 4.4 (95% confidence interval (CI): 3.7-7.5) and 4.7 (95% CI: 4.2-5.2), respectively; values of risk of OSAS-dependent MVAs were 2.83 (95% CI: 2.72-3.08) and 2.52 (95% CI: 2.07-3.08), respectively. The PAF showed weighed median and combined average values of 6.6 (95% CI: 4.3-9.8) and 7.3% (95% CI: 6.0-13.5), respectively. Our results show that about 7% of RTIs for a population of male drivers involved in MVAs are attributable to OSAS. This value can be used to assess the potential impact, on the reduction of incidence of the motor vehicle injuries, of prevention programs aimed at reducing the number of subjects with an undiagnosed and/or untreated OSAS.
© The Author(s) 2015.

Entities:  

Keywords:  Obstructive sleep apnea syndrome; motor vehicle accidents; population attributable fraction; public health; road traffic injuries

Mesh:

Year:  2015        PMID: 26170420     DOI: 10.1177/1479972315594624

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  9 in total

1.  Obstructive sleep apnea syndrome and public health: the Italian way.

Authors:  Antonio Sanna; Desiderio Passali; Michele De Benedetto; Giancarlo Marano; Michele Loglisci; Sergio Garbarino
Journal:  Sleep Breath       Date:  2017-04-12       Impact factor: 2.816

Review 2.  Excessive daytime sleepiness in obstructive sleep apnea: implications for driving licenses.

Authors:  Sergio Garbarino
Journal:  Sleep Breath       Date:  2019-07-24       Impact factor: 2.816

Review 3.  Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis.

Authors:  Sergio Garbarino; Ottavia Guglielmi; Antonio Sanna; Gian Luigi Mancardi; Nicola Magnavita
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 4.  Cost-effectiveness strategies in OSAS management: a short review.

Authors:  D M Toraldo; D Passali; A Sanna; F De Nuccio; L Conte; M De Benedetto
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-12       Impact factor: 2.124

5.  OSAS: its burden increases, not enough the awareness.

Authors:  Antonio Sanna; Donato Lacedonia
Journal:  Multidiscip Respir Med       Date:  2018-12-03

6.  Obstructive Sleep Apnea: A View from the Back Door.

Authors:  Silvano Dragonieri; Andras Bikov
Journal:  Medicina (Kaunas)       Date:  2020-04-25       Impact factor: 2.430

7.  Stimulants associated with reduced risk of hospitalization for motor vehicle accident injury in patients with obstructive sleep apnea-a nationwide cohort study.

Authors:  Yi-Chang Lin; Tien-Yu Chen; Wu-Chien Chien; Chi-Hsiang Chung; Hsin-An Chang; Yu-Chen Kao; Chien-Sung Tsai; Chih-Sheng Lin; Nian-Shen Tzeng
Journal:  BMC Pulm Med       Date:  2020-02-03       Impact factor: 3.317

8.  Study protocol of a randomized controlled trial of motivational interviewing-based intervention to improve adherence to continuous positive airway pressure in patients with obstructive sleep apnea syndrome: The MotivAir study.

Authors:  Giada Rapelli; Giada Pietrabissa; Licia Angeli; Gian Mauro Manzoni; Ilaria Tovaglieri; Elisa Perger; Sergio Garbarino; Paolo Fanari; Carolina Lombardi; Gianluca Castelnuovo
Journal:  Front Psychol       Date:  2022-08-25

9. 

Authors:  Antonio Sanna; Sergio Garbarino
Journal:  Med Lav       Date:  2019-10-29       Impact factor: 1.275

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.